Background: LSTR 3-Mix MP therapy is a non-instrumentation endodontic treatment designed for managing pulpally involved deciduous teeth. It offers a minimally invasive alternative to conventional pulpectomy, particularly in cases with anatomical complexities and physiologic root resorption. This study evaluates the clinical and radiological outcomes of LSTR 3-Mix MP therapy in treating chronic and necrotic pulp conditions in deciduous molars. Methods: This prospective clinical study was performed from November 2023 to October 2024 evaluated 60 deciduous molars in children aged 3–8 years, divided into Group A (vital pulp with chronic pulpitis) and Group B (non-vital pulp with/without periradicular lesions), conducted at Bangladesh Shishu Hospital & Institute and Shah Ali Dental Clinic, Dhaka. Results: Clinical success was achieved in 96.7% of cases in both groups, with complete resolution of symptoms, including pain, tenderness, swelling, and abscesses. Radiological success in Group A (vital teeth) reached 100%, with no pathological lesions observed. In Group B (non-vital teeth), periradicular radiolucency resolved in 73.3% of cases, decreased in 13.3%, and remained unchanged in 13.3%. Group A exhibited no swelling pre- or posttreatment, while in Group B, swelling resolved entirely by the second follow-up, with significant improvement noted earlier (p = 0.001, p = 0.042). Conclusion: LSTR 3-Mix MP therapy is a highly effective, minimally invasive treatment for deciduous molars with chronic and necrotic pulp conditions. It demonstrated excellent clinical and radiological outcomes, supporting its use as a promising alternative to conventional pulpectomy in pediatric patients.
Read full abstract